Birchview Capital, LP X Biotech Inc. Transaction History

Birchview Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$8.33 - $19.95 $249,900 - $598,500	-30,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$6.86 - $10.46 $137,200 - $209,200	20,000 Added 200.0%	30,000 $314,000
Q1 2019 May 03, 2019	BUY	$5.05 - $11.62 $50,500 - $116,199	10,000 New	10,000 $110,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $120M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.